Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery

被引:6
作者
Zheng, Chengbin [1 ]
Feng, Xingyu [2 ]
Zheng, Jiabin [2 ]
Yan, Qian [2 ]
Hu, Xu [2 ]
Feng, Huolun [2 ]
Deng, Zhenru [2 ]
Liao, Qianchao [2 ]
Wang, Junjiang [2 ]
Li, Yong [1 ,2 ]
机构
[1] South China Univ Technol, Guangdong Acad Med Sci, Sch Med, Dept Gen Surg,Guangdong Prov Peoples Hosp, 106 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Gen Surg, Guangzhou 510080, Guangdong, Peoples R China
关键词
lymphovascular invasion; adenocarcinoma of esophagogastric junction; risk factor; overall survival; disease-specific survival; LYMPH-NODE METASTASIS; RISK-FACTORS; ESOPHAGUS; EPIDEMIOLOGY; RECURRENCE; RESECTION; CANCER; EMBOLI;
D O I
10.2147/CMAR.S286512
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Tumors with lymphovascular invasion (LVI) are thought to be associated with lymph node metastasis and to lead to a worse prognosis. However, the effect of LVI on the prognosis of adenocarcinoma of esophagogastric junction (AEG) is still unclear. Patients and Methods: We retrospectively analyzed 224 consecutive patients with nonmetastatic AEG who underwent radical surgery in our hospital from 2004 to 2018. Inverse probability weighting (IPW) analysis was used to eliminate the selection bias. IPW-adjusted Kaplan-Meier curves and Cox proportional hazards models were used to compare diseasespecific survival (DSS) and overall survival (OS) between patients with and without LVI. Results: A total of 224 patients with non-metastatic AEG who underwent radical resection were included in the study and 96 (42.9%) patients developed LVI. Survival analysis showed that LVI were associated with worse DSS (hazard ratio (HR) = 3.12; 95% CI: 1.93-5.03) and worse OS (HR = 2.33; 95% CI: 1.61-3.38). The results were consistent across subgroups stratified by pathologic N stage. Subgroup analysis demonstrated that Siewert type III (HR= 3.20, 95% CI: 1.45-7.06) was associated with worse DSS, but not Siewert type I/II (HR= 1.46, 95% CI: 0.94-2.31, P-interaction=0.047). Conclusion: LVI are associated with worse prognosis in AEG. LVI had a worse effect on DSS in Siewert type III AEG than Siewert type I/II AEG.
引用
收藏
页码:12791 / 12799
页数:9
相关论文
共 34 条
[21]   Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma [J].
Matsuno, Kenshi ;
Ishihara, Ryu ;
Ohmori, Masayasu ;
Iwagami, Hiroyoshi ;
Shichijyo, Satoki ;
Maekawa, Akira ;
Kanesaka, Takashi ;
Yamamoto, Sachiko ;
Takeuchi, Yoji ;
Higashino, Koji ;
Uedo, Noriya ;
Matsunaga, Takashi ;
Morishima, Toshitaka ;
Miyashiro, Isao .
JOURNAL OF GASTROENTEROLOGY, 2019, 54 (09) :784-791
[22]   Lymphovascular invasion and lymph node metastasis rates in papillary adenocarcinoma of the stomach: implications for endoscopic resection [J].
Min, Byung-Hoon ;
Byeon, Sun-Ju ;
Lee, Jun Haeng ;
Kim, Kyoung-Mee ;
An, Ji Yeong ;
Choi, Min Gew ;
Lee, Jun Ho ;
Sohn, Tae Sung ;
Bae, Jae Moon ;
Kim, Sung .
GASTRIC CANCER, 2018, 21 (04) :680-688
[23]   Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery [J].
Pei, Qian ;
Zhu, Hong ;
Tan, Fengbo ;
Yu, Nanhui ;
Zhou, Zhongyi ;
Zhou, Yuan ;
Song, Xiangping ;
Li, Yuqiang ;
Tao, Yiming ;
Zhang, Sai ;
Li, Liling ;
Li, Qingling ;
Pei, Haiping .
ONCOTARGET, 2016, 7 (35) :57268-57276
[24]   Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer [J].
Pyo, Jeung Hui ;
Lee, Hyuk ;
Min, Yang Won ;
Min, Byung-Hoon ;
Lee, Jun Haeng ;
Kim, Kyoung-Mee ;
Yoo, Heejin ;
Ahn, Soohyun ;
Kim, Jae J. .
GASTRIC CANCER, 2018, 21 (04) :672-679
[25]   Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals [J].
Rice, T. W. ;
Ishwaran, H. ;
Hofstetter, W. L. ;
Kelsen, D. P. ;
Apperson-Hansen, C. ;
Blackstone, E. H. .
DISEASES OF THE ESOPHAGUS, 2016, 29 (08) :897-905
[26]  
Siewert JR, 2000, ANN SURG, V232, P353
[27]  
Tomlinson JS, 2001, CANCER RES, V61, P5231
[28]   Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort [J].
Urabe, Masayuki ;
Ushiku, Tetsuo ;
Shinozaki-Ushiku, Aya ;
Iwasaki, Akiko ;
Yamazawa, Sho ;
Yamashita, Hiroharu ;
Seto, Yasuyuki ;
Fukayama, Masashi .
CANCER MEDICINE, 2018, 7 (10) :5145-5154
[29]   Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction [J].
von Rahden, BHA ;
Stein, HJ ;
Feith, M ;
Becker, K ;
Siewert, JR .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :874-879
[30]   Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma [J].
Wang, Zhen ;
Chen, Peng ;
Wang, Feng ;
Lin, Liyan ;
Liu, Shuoyan .
THORACIC CANCER, 2019, 10 (02) :150-155